Entera Bio Ltd.
ENTX
$2.89
$0.020.70%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -100.00% | -100.00% | -76.80% | 25.25% | 191.23% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -100.00% | -100.00% | -76.80% | 25.25% | 191.23% |
| Cost of Revenue | -100.00% | -100.00% | -75.58% | 37.78% | 245.83% |
| Gross Profit | -- | -100.00% | -100.00% | -100.00% | -100.00% |
| SG&A Expenses | 6.06% | 3.17% | 8.44% | 8.21% | 19.29% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 33.89% | 21.30% | 18.48% | 17.59% | 24.58% |
| Operating Income | -35.99% | -23.98% | -20.28% | -17.51% | -23.47% |
| Income Before Tax | -60.87% | -22.82% | -20.07% | -17.31% | -24.46% |
| Income Tax Expenses | -- | -- | -- | -- | -51.72% |
| Earnings from Continuing Operations | -60.66% | -22.65% | -19.89% | -17.47% | -24.20% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -60.66% | -22.65% | -19.89% | -17.47% | -24.20% |
| EBIT | -35.99% | -23.98% | -20.28% | -17.51% | -23.47% |
| EBITDA | -36.17% | -24.20% | -20.55% | -17.76% | -23.78% |
| EPS Basic | -36.49% | -1.67% | 2.21% | 6.22% | 2.36% |
| Normalized Basic EPS | -36.73% | -1.80% | 2.09% | 6.33% | 2.08% |
| EPS Diluted | -36.49% | -1.67% | 2.21% | 6.22% | 2.36% |
| Normalized Diluted EPS | -36.73% | -1.80% | 2.09% | 6.33% | 2.08% |
| Average Basic Shares Outstanding | 15.33% | 20.19% | 22.58% | 25.06% | 26.27% |
| Average Diluted Shares Outstanding | 15.33% | 20.19% | 22.58% | 25.06% | 26.27% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |